What's in Partners in Health's pipeline?

Partners in Health has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Partners in Health's portfolio?

Top competitors by shared drug class: Ain Shams University, Almaza Military Fever Hospital, Egyptian Liver Hospital, Federal University of São Paulo, HaEmek Medical Center, Israel.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/partners-in-health.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Partners in Health — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Partners in Health pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
sofosbubir/velpatasvir	sofosbubir/velpatasvir	marketed	Direct-acting antiviral (DAA) combination	HCV NS5B polymerase and NS5A protein	Virology/Hepatology
sofosbubir/velpatasvir/voxilaprevir	sofosbubir/velpatasvir/voxilaprevir	marketed	Direct-acting antiviral (DAA) combination	HCV NS5B polymerase, NS5A protein, NS3/4A protease	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 1
Virology/Hepatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 1 shared drug class
Almaza Military Fever Hospital · 1 shared drug class
Egyptian Liver Hospital · 1 shared drug class
Federal University of São Paulo · 1 shared drug class
HaEmek Medical Center, Israel · 1 shared drug class
Hannover Medical School · 1 shared drug class
HepNet Study House, German Liverfoundation · 1 shared drug class
ANRS, Emerging Infectious Diseases · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Partners in Health:

Cite this brief

Drug Landscape (2026). Partners in Health — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/partners-in-health. Accessed 2026-05-17.